US 11779601
Diagnostic methods for T cell therapy
granted A61KA61K2239/31A61K2239/38
Quick answer
US patent 11779601 (Diagnostic methods for T cell therapy) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Oct 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K2239/31, A61K2239/38, A61K2239/48, A61K2300/00